BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7474410)

  • 1. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
    Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient with extensive small cell lung cancer given moderately dose-intensified chemotherapy and peripheral blood stem cell support.
    Shimizu E; Takaue Y; Yamamoto A; Ogura T; Sone S
    Jpn J Clin Oncol; 1995 Oct; 25(5):213-7. PubMed ID: 7474410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mega-dose chemotherapy with peripheral blood stem cell transplantation (PBS-CT) for small cell lung cancer (SCLC)].
    Chou T; Yokoyama A; Yoshizawa H; Hoshino M; Ebe T; Kurita Y; Arakawa M
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1741-8. PubMed ID: 7574804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multimodality therapy for small-cell lung cancer].
    Yokoyama A
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():405-11. PubMed ID: 9369915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent issue in the treatment of small-cell lung cancer].
    Ueoka H; Hiraki S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1665-70. PubMed ID: 9757190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y; Inoue K; Hara N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [International consensus for lung cancer treatment].
    Naruse I; Saijo N
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():451-9. PubMed ID: 9369922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.